Another factor that the IFN signaling axis may impact, potentially related to tumor progression or regression, is the expression of MHC class I. The epigenetic silencing of MHC class I genes is significant in prostate cancer [126,127]. The gene discussed is IFNA1; the disease is prostate carcinoma.